{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:27:25Z","timestamp":1778750845505,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"European Community's Seventh Framework Programme (FP7)","award":["223034"],"award-info":[{"award-number":["223034"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.ijantimicag.2012.08.002","type":"journal-article","created":{"date-parts":[[2012,10,12]],"date-time":"2012-10-12T01:30:41Z","timestamp":1350005441000},"page":"527-532","source":"Crossref","is-referenced-by-count":69,"title":["Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome\u00ae in mice infected with Trypanosoma cruzi strains"],"prefix":"10.1016","volume":"40","author":[{"given":"Sabrina","family":"Cencig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Coltel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine","family":"Truyens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Carlier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0005","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease","volume":"375","author":"Rassi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0010","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/nature09221","article-title":"Chagas disease: a new worldwide challenge","volume":"465","author":"Coura","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0015","doi-asserted-by":"crossref","first-page":"e1250","DOI":"10.1371\/journal.pntd.0001250","article-title":"Congenital Chagas disease: recommendations for diagnosis, treatment and control of newborns, siblings and pregnant women","volume":"5","author":"Carlier","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.actatropica.2009.10.023","article-title":"Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches","volume":"115","author":"Urbina","year":"2010","journal-title":"Acta Trop"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0025","doi-asserted-by":"crossref","first-page":"724","DOI":"10.7326\/0003-4819-144-10-200605160-00006","article-title":"Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial","volume":"144","author":"Viotti","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0030","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0035-9203(87)90020-4","article-title":"Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease","volume":"81","author":"Filardi","year":"1987","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0035","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0035-9203(88)90208-8","article-title":"Comparative studies of drug susceptibility of five strains of Trypanosoma cruzi in vivo and in vitro","volume":"82","author":"Neal","year":"1988","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0040","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1086\/656917","article-title":"Tolerance and safety of nifurtimox in patients with chronic Chagas disease","volume":"51","author":"Jackson","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0045","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/14787210.7.2.157","article-title":"Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities","volume":"7","author":"Viotti","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0050","doi-asserted-by":"crossref","first-page":"e484","DOI":"10.1371\/journal.pntd.0000484","article-title":"New, improved treatments for Chagas disease: from the R&D pipeline to the patients","volume":"3","author":"Ribeiro","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2012.08.002_bib0055","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1590\/S0074-02762009000900041","article-title":"Ergosterol biosynthesis and drug development for Chagas disease","volume":"104","author":"Urbina","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijantimicag.2010.03.006","article-title":"A comparative study of posaconazole and benznidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease","volume":"36","author":"Olivieri","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0065","doi-asserted-by":"crossref","first-page":"e1216","DOI":"10.1371\/journal.pntd.0001216","article-title":"Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with AmBisome","volume":"5","author":"Cencig","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0070","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4269\/ajtmh.1999.61.193","article-title":"In vitro and in vivo activity of amphotericin B-lipid formulations against experimental Trypanosoma cruzi infections","volume":"61","author":"Yardley","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0075","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jac\/45.6.819","article-title":"A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas\u2019 disease","volume":"45","author":"Ara\u00fajo","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0080","doi-asserted-by":"crossref","first-page":"e22155","DOI":"10.1371\/journal.pone.0022155","article-title":"Combined treatment of heterocyclic analogues and benznidazole upon Trypanosoma cruzi in vivo","volume":"6","author":"Batista Dda","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0085","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1128\/AAC.01454-07","article-title":"Buthionine sulfoximine has anti-Trypanosoma cruzi activity in a murine model of acute Chagas\u2019 disease and enhances the efficacy of nifurtimox","volume":"52","author":"Fa\u00fandez","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0090","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00436-010-2002-z","article-title":"Association of clomipramine and allopurinol for the treatment of the experimental infection with Trypanosoma cruzi","volume":"107","author":"Gobbi","year":"2010","journal-title":"Parasitol Res"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0095","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-3024.2009.01185.x","article-title":"Enhanced protection by melatonin and meloxicam combination in experimental infection by Trypanosoma cruzi","volume":"32","author":"Oliveira","year":"2010","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0100","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1128\/AAC.05575-11","article-title":"In vitro and in vivo trypanocidal synergistic activity of N-butyl-1-(4-dimethylamino)phenyl-1,2,3,4-tetrahydro-\u03b2-carboline-3-carboxamide associated with benznidazole","volume":"56","author":"Valdez","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0105","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1021\/jm050691f","article-title":"Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole","volume":"49","author":"Benaim","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0110","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1128\/IAI.55.10.2496-2501.1987","article-title":"Pregnancy and humoral immune response in mice chronically infected by Trypanosoma cruzi","volume":"55","author":"Carlier","year":"1987","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0115","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nm1744","article-title":"Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease","volume":"14","author":"Bustamante","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0166-6851(03)00093-8","article-title":"Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR","volume":"129","author":"Cummings","year":"2003","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0125","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/AAC.44.1.150-155.2000","article-title":"Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts","volume":"44","author":"Molina","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2710.2009.01055.x","article-title":"Tolerability and safety profile of posaconazole: evaluation of 18 controlled studies in healthy volunteers","volume":"34","author":"Moton","year":"2009","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0135","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/AAC.05135-11","article-title":"Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation","volume":"56","author":"Hall","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0140","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.2174\/156802611796575894","article-title":"Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives","volume":"11","author":"Wilkinson","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1590\/S0074-02761993000100023","article-title":"An experimental and clinical assay with ketoconazole in the treatment of Chagas disease","volume":"88","author":"Brener","year":"1993","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.ijantimicag.2012.08.002_bib0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1128\/AAC.32.2.241","article-title":"Differences in resistance to reinfection with low and high inocula of Trypanosoma cruzi in chagasic mice treated with nifurtimox and relation to immune response","volume":"32","author":"Cabeza","year":"1988","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912003366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912003366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T18:42:24Z","timestamp":1594752144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857912003366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0924857912003366"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.08.002","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}